Health
Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study – THE WEEK
What is very clear is that two doses are required to maximise protection
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…
Continue Reading
-
General23 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire
-
General22 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
General21 hours agoBathurst 1000 quick hits: Chaz Mostert drinks beer with fans, Erebus owner protests, and drama on Mount Panorama
-
Noosa News19 hours agoFatal Traffic Crash, South Bingera